Results 171 to 180 of about 134,100 (245)

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

Male infertility as a late side effect of oncological treatment of Hodgkin lymphoma in childhood and adolescents and the possible prevention. [PDF]

Front Oncol
Prusak M, Brylka K, Derwich K.
europepmc   +1 more source

MTV‐guided radiotherapy bridging in large B‐cell lymphoma patients receiving CD19 CAR T‐cell therapy

British Journal of Haematology, EarlyView.
Andrea Kuhnl, S. Bouziana, S. F. Barrington, S. Galani, T. Menne, M. Northend, L. Stevens, S. Kamat, W. Osborne, R. Johnson, E. Kumar, R. Sanderson, P. E. M. Patten, R. Benjamin, J. Frew, R. Prestwich, J. L. Brady, N. G. Mikhaeel   +17 more
wiley   +1 more source

Assessing Factors in Time to Diagnosis for Head-and-Neck Lymphoma. [PDF]

Cureus
Kondapaneni R, Du EY, Gates CK, Bhanderi VK, Tassone PT.   +4 more
europepmc   +1 more source

Reporting and representation of race and ethnicity data in phase III clinical trials for hematological malignancies. [PDF]

Future Sci OA
Wang T, Banerjee A, Gifkins D.
europepmc   +1 more source

A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma

British Journal of Haematology, EarlyView.
Marco A. Salvino, Flavio A. V. Luisi, Mara A. Pianovski, Franca Fagioli, Sidnei Epelman, Luciana B. A. Lima, Vicente O. Filho, Marco Zecca, Claudio Favre, Ryoji Kobayashi, Yuhki Koga, Rizvan Bush, Yulia Sidi, Xiaofei Zhou, Xiang Bai, Frank Campana, Franco Locatelli   +16 more
wiley   +1 more source

Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30‐positive cutaneous T‐cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce.
Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser   +10 more
wiley   +1 more source

Burkitt Lymphoma Presentation with Oropharyngeal Mass of Tonsillar Fossa: A Case Report. [PDF]

Clin Pract Cases Emerg Med
Rosario DA, Aronson S, Zerzan J.
europepmc   +1 more source

First‐line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial

British Journal of Haematology, EarlyView.
Anthony S. Stein, Andrew A. Lane, Kendra L. Sweet, Sumithira Vasu, Alessandra Tosolini, John Katsetos, Marina Konopleva, Naveen Pemmaraju   +7 more
wiley   +1 more source

Follicular non-Hodgkin lymphoma recurrence in an uncommon site: the lacrimal caruncle. [PDF]

J Surg Case Rep
Ozkul E, Mangan MS, Buttanri IB, Mazmanoglu Atilman S.   +3 more
europepmc   +1 more source